Zobrazeno 1 - 10
of 402
pro vyhledávání: '"James C Fang"'
Autor:
Catherine G Derington, Jordana B Cohen, April F Mohanty, Tom H Greene, James Cook, Jian Ying, Guo Wei, Jennifer S Herrick, Vanessa W Stevens, Barbara E Jones, Libo Wang, Alexander R Zheutlin, Andrew M South, Thomas C Hanff, Steven M Smith, Rhonda M Cooper-DeHoff, Jordan B King, G Caleb Alexander, Dan R Berlowitz, Faraz S Ahmad, M Jason Penrod, Rachel Hess, Molly B Conroy, James C Fang, Michael A Rubin, Srinivasan Beddhu, Alfred K Cheung, Weiming Xian, William S Weintraub, Adam P Bress
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0248080 (2021)
BackgroundAngiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) may positively or negatively impact outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the associa
Externí odkaz:
https://doaj.org/article/9f95d8c5dcd04d9b8f8dc9e9a0d7a189
Autor:
Ambarish Pandey, Jarett D. Berry, Mark H. Drazner, James C Fang, W. H. Wilson Tang, Justin L. Grodin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 21 (2018)
Background The prognostic interrelationship between natriuretic peptide (NP) levels and body mass index (BMI) among patients with chronic stable heart failure with preserved ejection fraction is not well characterized. Methods and Results Participant
Externí odkaz:
https://doaj.org/article/da261c75cea44b038502cfb26c6aa2d4
Autor:
Joshua A. Jacobs, PharmD, Spencer J. Carter, MD, Griffin Bullock, MD, Jessica R. Carey, PharmD, Irene Z. Pan, PharmD, M. Shea Kinsey, PharmD, MBA, MHSA, MS, Alexander R. Zheutlin, MD, MS, Chris J. Kapelios, MD, Shilpa Raju, MD, James C. Fang, MD, Kevin S. Shah, MD, Adam P. Bress, PharmD, MS
Publikováno v:
JACC: Advances, Vol 3, Iss 10, Pp 101250- (2024)
Background: Nearly one-half of patients admitted with acute decompensated heart failure (ADHF) are discharged with unresolved congestion, elevating rehospitalization risk. This may be due to suboptimal intravenous (IV) loop diuretic dosing, which may
Externí odkaz:
https://doaj.org/article/701d97fe4656429bac2ad24a4084cb01
Autor:
Christos P. Kyriakopoulos, Iosif Taleb, Eleni Tseliou, Konstantinos Sideris, Rana Hamouche, Eleni Maneta, Marisca Nelson, Ethan Krauspe, Sean Selko, Joseph R. Visker, Elizabeth Dranow, Matthew L. Goodwin, Rami Alharethi, Omar Wever‐Pinzon, James C. Fang, Josef Stehlik, Craig H. Selzman, Thomas C. Hanff, Stavros G. Drakos
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 14 (2024)
Background Type 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity and mortality. We sought to investigate the effect of glycemia on functional cardiac improvement, morbidity, and mortality in durable left ventricul
Externí odkaz:
https://doaj.org/article/f8ddf47e36a0402ab73031433e39ce0d
Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study
Autor:
Adhish Agarwal, Srinivasan Beddhu, Robert Boucher, Veena Rao, Nirupama Ramkumar, Aylin R. Rodan, Jacob Fang, Brandi M. Wynne, Stavros G. Drakos, Thomas Hanff, Alfred K. Cheung, James C. Fang
Publikováno v:
Physiological Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Abstract The pathophysiology behind sodium retention in heart failure with preserved ejection fraction (HFpEF) remains poorly understood. We hypothesized that patients with HFpEF have impaired natriuresis and diuresis in response to volume expansion
Externí odkaz:
https://doaj.org/article/9ffcb949c276407eb186eebff289d4e5
Autor:
Ankeet S. Bhatt, Muthiah Vaduganathan, Brian L. Claggett, Ian J. Kulac, Inder S. Anand, Akshay S. Desai, James C. Fang, Adrian F. Hernandez, Pardeep S. Jhund, Mikhail N. Kosiborod, Marc S. Sabatine, Sanjiv J. Shah, Orly Vardeny, John J. V. McMurray, Scott D. Solomon, Thomas A. Gaziano
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 5 (2024)
Background The sodium glucose cotransporter‐2 inhibitors are guideline‐recommended to treat heart failure across the spectrum of left ventricular ejection fraction; however, economic evaluations of adding sodium glucose cotransporter‐2 inhibito
Externí odkaz:
https://doaj.org/article/53dbb9210acf48109e85b415aa980e57
Autor:
G.Michael Felker, Peter Buttrick, Anthony Rosenzweig, E. Dale Abel, Larry A. Allen, Michael Bristow, Saumya Das, Adam D. DeVore, Stavros G. Drakos, James C. Fang, Jane E. Freedman, Adrian F. Hernandez, Dean Y. Li, Timothy A. McKinsey, Christopher Newton‐Cheh, Joseph G. Rogers, Ravi V. Shah, Svati H. Shah, Josef Stehlik, Craig H. Selzman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 18 (2022)
Heart failure remains among the most common and morbid health conditions. The Heart Failure Strategically Focused Research Network (HF SFRN) was funded by the American Heart Association to facilitate collaborative, high‐impact research in the field
Externí odkaz:
https://doaj.org/article/fbf3fa3979cc4affabde739b5bcf3cec
Autor:
April F. Mohanty, Emily B. Levitan, Jordan B. King, John A. Dodson, Orly Vardeny, James Cook, Jennifer S. Herrick, Tao He, Olga V. Patterson, Patrick R. Alba, Patricia A. Russo, Engels N. Obi, Michelle E. Choi, James C. Fang, Adam P. Bress
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 20 (2021)
Background Sacubitril/valsartan, a first‐in‐class angiotensin receptor neprilysin inhibitor, received US Food and Drug Administration approval in 2015 for heart failure with reduced ejection fraction (HFrEF). Our objective was to describe the sac
Externí odkaz:
https://doaj.org/article/b3e4d96313984c458e4300e40728aa41
Autor:
Sagar Ranka, Ioannis Mastoris, Navin K. Kapur, Ryan J. Tedford, Aniket Rali, Prakash Acharya, Robert Weidling, Amandeep Goyal, Andrew J. Sauer, Bhanu Gupta, Nicholas Haglund, Kamal Gupta, James C. Fang, JoAnn Lindenfeld, Zubair Shah
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background The usefulness of right heart catherization (RHC) has long been debated, and thus, we aimed to study the real‐world impact of the use of RHC in cardiogenic shock. Methods and Results In the Nationwide Readmissions Database using Internat
Externí odkaz:
https://doaj.org/article/d571cc0a302940f5933987651d3243dc
Autor:
David E. Lanfear, Joyce N. Njoroge, Kirkwood F. Adams, Inder Anand, James C. Fang, Felix Ramires, Karen Sliwa-Hahnle, Aysha Badat, Lesley Burgess, Eiran Z. Gorodeski, Celeste Williams, Rafael Diaz, Gary M. Felker, John J.V. McMurray, Marco Metra, Scott Solomon, Zi Michael Miao, Brian L. Claggett, Stephen B. Heitner, Stuart Kupfer, Fady I. Malik, John R. Teerlink
Publikováno v:
JACC: Heart Failure. 11:569-579